This study indicated that EGFR/TP53 co-variant and EGFR/PIK3CA co-variant were largely expressed among lung cancer patients, knowing both TP53 and PIK3CA variants are important for survival prognosis in lung cancer [9]. Here, PIK3CA is linked to lung carcinoma.